CNTX
Context Therapeutics·NASDAQ
--
--(--)
--
--(--)
CNTX fundamentals
Context Therapeutics (CNTX) released its earnings on Aug 6, 2025: revenue was 0 (YoY 0.00%), met estimates; EPS was -0.09 (YoY -125.00%), missed estimates.
Revenue / YoY
0
0.00%
EPS / YoY
-0.09
-125.00%
Report date
Aug 6, 2025
EPS
Revenue
Revenue & Expenses
Key Indicators
Context Therapeutics (CNTX) key financial stats and ratios, covering profitability, financial health, and leverage.
Context Therapeutics (CNTX)'s revenue and profit trends over recent years, visualized with a waterfall chart to showcase the revenue-to-profit funnel.
Trend
Breakdown
Context Therapeutics (CNTX)'s asset and liability trends over recent years, visualized with a waterfall chart to illustrate changes in its asset-liability structure.
Trend
Breakdown
Context Therapeutics (CNTX)'s cash flow trends over recent years, visualized with a waterfall chart to illustrate changes in its operating, investing, and financing cash flows.
Trend
Breakdown
Where does Context Therapeutics (CNTX) generate its revenue? Explore its key revenue streams and top earning regions.
By Business
Data source:
By Region
Data source:
Track Context Therapeutics (CNTX) Dividend Yield, Payout Ratio & Sustainability Through Its Dividend History
Payout Ratio
Dividend Yield
You can ask Aime
What is the revenue and EPS growth rate for Context Therapeutics year over year?Did Context Therapeutics beat or miss consensus estimates last quarter?What is Context Therapeutics's latest dividend and current dividend yield?What were the key takeaways from Context Therapeutics's earnings call?What factors drove the changes in Context Therapeutics's revenue and profit?What is Context Therapeutics's gross profit margin?What were the key takeaways from Context Therapeutics’s earnings call?What guidance did Context Therapeutics's management provide for the next earnings period?
